Implantable bioartificial kidney

During hemodialysis, blood passes through a filter outside the body to remove waste and extra water. Could an implanted device do enough of this work continuously to replace dialysis safely? The proposed bioartificial kidney has two jobs: a membrane filters fluid out of blood, then living kidney cells process that fluid, returning useful water and salts while leaving waste for the bladder.[1] [3]

Hemodialysis removes waste and excess fluid by passing blood through an external filter. Can an implanted membrane and living kidney cells provide sustained, safe support instead? The proposed integrated device separates filtration from selective cellular processing. Its hemofilter uses tiny silicon pores and the blood-pressure difference to produce ultrafiltrate. Tubule cells in a bioreactor would return needed water and solutes to circulation and concentrate the rest for discharge to the bladder. The project’s first-version filtration target of 20–30 ml/min is a development goal.

The 2023 primary study tested the cell-containing bioreactor component in pigs for three or seven days. A nanopore barrier allowed exchange with the blood while separating human renal cells from the host. The implants maintained blood flow and high cell viability, with transporter-gene expression and vitamin D activation as functional evidence. The pigs received antiplatelet agents. These results support component feasibility; they are not a test of long-term integrated dialysis replacement.[1] [3]

Short animal tests support parts of the design. A 2023 study kept human kidney cells alive in an implanted bioreactor for up to seven days in pigs; it did not demonstrate a complete dialysis replacement. The filter, cells and fluid outlet still need to work together for long periods without clots, blockage or loss of cell function.[1] [2] [3]

That experiment was designed mainly around cell survival; it did not collect the outgoing ultrafiltrate or establish clinically useful water and solute transport. Larger cell numbers and longer implantation could change the immune response and blood compatibility. Durable filtration, cell processing and controlled urine output must therefore be demonstrated together. Complete replacement of every kidney function is outside this page’s requirement.[1] [3]

An implant that provided sustained useful function could reduce the time and disruption of repeated dialysis sessions. That benefit depends on keeping both blood treatment and fluid balance reliable; it is a goal of the device, not an outcome already shown in people.[1] [2] [3]

An artificial filter removes substances without the full selective processing of kidney tubules. Coupling the two functions could provide continuous support while preserving useful constituents of blood, potentially easing dependence on intermittent dialysis. The need to avoid clotting and fouling also connects membrane geometry and surface chemistry directly to the viability of the cells and the usefulness of the whole implant.[1] [2] [3]